@article{02e3b46e85ce44d09b3c7075410b578a,
title = "New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases",
abstract = "N/A",
keywords = "Anti-Bacterial Agents, Antibiotics, Diverticular Diseases, Gastrointestinal Microbiome, Gut microenvironment, Hepatic Encephalopathy, Humans, Irritable Bowel Syndrome, Probiotics, Randomized Controlled Trials as Topic, Rifamycins, Rifaximin, Therapeutic treatments, Anti-Bacterial Agents, Antibiotics, Diverticular Diseases, Gastrointestinal Microbiome, Gut microenvironment, Hepatic Encephalopathy, Humans, Irritable Bowel Syndrome, Probiotics, Randomized Controlled Trials as Topic, Rifamycins, Rifaximin, Therapeutic treatments",
author = "Bajaj, {Jasmohan S.} and Giovanni Barbara and Dupont, {Herbert L.} and F. Mearin and Antonio Gasbarrini and Jan Tack",
year = "2018",
doi = "10.1016/j.dld.2018.04.020",
language = "English",
volume = "50",
pages = "741--749",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "-Roma: Editrice Gastroenterologica Italiana. -Ospedaletto Pisa: Pacini",
}